Skip to main content
Frontiers in Microbiology logoLink to Frontiers in Microbiology
. 2016 Feb 12;7:141. doi: 10.3389/fmicb.2016.00141

Mass Spectrometry Offers Insight into the Role of Ser/Thr/Tyr Phosphorylation in the Mycobacteria

Bridget Calder 1, Claudia Albeldas 1, Jonathan M Blackburn 1,*, Nelson C Soares 1,*
PMCID: PMC4751927  PMID: 26904014

Abstract

Phosphorylation is a post translational modification which can rapidly regulate biochemical pathways by altering protein function, and has been associated with pathogenicity in bacteria. Once engulfed by host macrophages, pathogenic bacteria are exposed to harsh conditions and must respond rapidly in order to survive. The causative agent of TB, Mycobacterium tuberculosis, is unusual amongst the bacteria because it can survive within the host macrophage for decades in a latent state, demonstrating a remarkable capacity to successfully evade the host immune response. This ability may be mediated in part by regulatory mechanisms such as ser/thr/tyr phosphorylation. Mass spectrometry-based proteomics has afforded us the capacity to identify hundreds of phosphorylation sites in the bacterial proteome, allowing for comparative phosphoproteomic studies in the mycobacteria. There remains an urgent need to validate the reported phosphosites, and to elucidate their biological function in the context of pathogenicity. However, given the sheer number of putative phosphorylation events in the mycobacterial proteome, and the technical difficulty of assigning biological function to a phosphorylation event, it will not be trivial to do so. There are currently six published phosphoproteomic investigations of a member of mycobacteria. Here, we combine the datasets from these studies in order to identify commonly detected phosphopeptides and phosphosites in order to present high confidence candidates for further validation. By applying modern mass spectrometry-based techniques to improve our understanding of phosphorylation and other PTMs in pathogenic bacteria, we may identify candidates for therapeutic intervention.

Keywords: post-translational modification, phosphorylation, mycobacteria, tuberculosis, proteomics, phosphoproteomics, mass spectrometry, virulence

Introduction

Proteins are the bioactive molecule in the cell, and contribute to survival, growth, and reproduction by interacting with each other, and with metabolites, lipids, nucleic acids and carbohydrates, and catalyzing biological reactions (Nørregaard Jensen, 2004). Protein biosynthesis and degradation are tightly regulated by complex biochemical systems in response to the changing needs of the cell. However, there is an additional mechanism which allows cells to respond rapidly and efficiently to the external and internal conditions. Post translational modification (PTM) by selective covalent processing of proteins—by proteolytic cleavage or the addition of a modifying group—can drastically alter the properties of a protein (Mann and Jensen, 2003; Mijakovic, 2010; Stülke, 2010). Post translational modifications add a layer of complexity to both bacterial and eukaryotic mechanisms of adaptation to the surrounding environment.

Modern mass spectrometry (MS) has enabled us to perform high throughput analysis of PTMs. Since modified proteins usually occur at low abundance, an enrichment process is typically carried out for a specific PTM prior to MS analysis (Semanjski and Macek, 2016). This results in increased resolution, sensitivity and fragmentation (Cain et al., 2014) and has contributed to the identification and localization of phosphosites in many species, including pathogenic bacteria. Once thought to be found only in eukaryotes, the discovery of Hanks-type family of kinases in bacteria indicates that a complex bacterial phosphorylation-mediated signaling system exists (Bakal and Davies, 2000). These serine/threonine protein kinases (STPKs) add a phosphate group to a serine/threonine, while BY-kinases add phosphate groups to Tyrosine residues. PTMs in bacteria have been linked to pathogenicity, virulence, resistance and persistence, and are vital for survival (Ge and Shan, 2011; Van Els et al., 2014). MS-based phosphoproteomic analysis has been carried out in a number of bacterial species, including Bacillus subtilis (Macek et al., 2007), Escherichia coli (Macek et al., 2008; Soares et al., 2013), Streptococcus pneumonia (Sun et al., 2009) Listeria monocytogenes (Misra et al., 2011), Acinetobacter baumanii (Soares et al., 2014), and Mycobacterium tuberculosis.

The role of phosphorylation in M. tuberculosis

The bacillus M. tuberculosis is the causative agent of tuberculosis (TB), a leading global health crisis which has claimed millions of lives by continuing to evade clinical intervention. This is largely due to its ability to lay dormant for many years in the body, resurfacing if the hosts' immune system becomes compromised (Gengenbacher and Kaufmann, 2012). When the bacilli enter the human lung, they are ingested by alveolar macrophage cells of the human immune system. The macrophages respond by becoming acidic and exposing the pathogen to lytic enzymes, oxygenated lipids, fatty acids, and reactive oxygen and nitrogen intermediates (Schnappinger et al., 2003). In order to survive in the adverse environment of the macrophage, M. tuberculosis needs to react swiftly, which is possible through the regulatory mechanisms afforded by PTMs (Cain et al., 2014). Mycobacterial STPK phosphorylation has been long associated with pathogenicity (Sherman and Grundner, 2014), which has driven efforts to improve our understanding of the role of phosphorylation in M. tuberculosis (Prisic and Husson, 2014). Currently, there are six published manuscripts describing the phosphoproteome of a member of the Mycobacteria—M. tuberculosis H37Rv (Prisic et al., 2010; Kusebauch et al., 2014), M. smegmatis, and M. bovis BCG (Nakedi et al., 2015; Zheng et al., 2015), a clinical isolate of M. tuberculosis Beijing lineage (Fortuin et al., 2015) and a ΔpknE deletion mutant strain of M. tuberculosis (Parandhaman et al., 2014b). While these studies are discussed in more detail below, a summary of the methods used and relevant results for each of them is presented in Table 1. A major difficulty in comparing phosphoproteomic studies is that we cannot compare those phosphosites that were uniquely identified by each study, because it is impossible to determine whether that uniqueness is as a result of biological differences or the stochastic nature of discovery-driven MS-based proteomics. The only available study in the mycobacteria where those uniquely detected phosphosites are comparable is Nakedi et al. (2015), because the study compared two strains under the same experimental conditions. In this case, a relevant conclusion drawn by the authors is that the phosphosite patterns detected in M. smegmatis and M. bovis BCG are often species specific and these phosphorylation events are commonly occurring on entirely different peptides.

Table 1.

An overview of the methods used and results generated in the six currently available published studies investigating phosphorylation in the mycobacteria using mass spectrometry.

References Strain/species Fractionation method Enrichment method # Proteins identified # Sites %S %T %Y Major conclusions
Prisic et al., 2010 M. tuberculosis H37Rv SDS PAGE Titanium dioxide beads 301 516 40 60 - A broad range of proteins are phosphorylated on S/T residues in M. tuberculosis, and may contribute to virulence.
Kusebauch et al., 2014 M. tuberculosis H37Rv None IMAC with PHOS-select iron affinity gel (Sigma) and then Titan-sphere Phos-TiO kit (GL Sciences Inc.) 232 32 64 4 Tyr phosphorylation does occur in M. tuberculosis, a Tyr phosphosite of PknB in is important in regulating growth and therefore may affect survival in stress conditions.
Parandhaman et al., 2014b M. tuberculosis H37Rv, M. tuberculosisΔPknE mutant 2D SDS PAGE None 68 N/A N/A N/A N/A Proteins which are affected by the ΔPknE mutation under NO stress are hypothesized to contribute to pathogenicity of M. tuberculosis.
Nakedi et al., 2015 M. bovis BCG None TiO2 beads 203 289 35 61.6 3.1 Differences between fast and slow growing mycobacteria may be related to phosphorylation, with the ability to respond rapidly to stress associated with metabolic cost and slow growth.
M. smegmatis None TiO2 beads 76 106 39.47 57.02 3.51
Fortuin et al., 2015 M. tuberculosis clinical isolate Strong cation exchange TiO2 beads 214 414 38 59 3 Novel phosphorylation events were identified in this clinical strain, expanding our understanding of phosphorylation in M. tuberculosis.
Zheng et al., 2015 M. bovis BCG SDS PAGE or offline ACN fractionation TiO2 beads 398 659 39.5 48.7 11.8 Gel-based and gel-free phosphoproteomic analysis of M. tuberculosis may identify new pharmacological targets for drug development.

The identification of PTMs which contribute to the pathogenicity of M. tuberculosis by enhancing its ability to survive in the macrophage is of great interest to the medical community, as these represent attractive candidates for therapeutic intervention. This review will focus specifically on the use of MS-based techniques which have been used to identify phosphorylated proteins in the mycobacteria, with particular focus on the identification of phosphorylation sites which may contribute to pathogenicity and are conserved across pathogenic strains of mycobacteria.

Comparative phosphoproteomic analysis of mycobacteria

Prisic et al. (2010) were the first to present a global view of the phosphoproteome of M. tuberculosis H37Rv. They used in-gel tryptic digest to proteolytically prepare samples of H37Rv lysate grown under conditions of NO stress, oxidative stress, hypoxia and using glucose, or acetate as a carbon source. A total of 152 samples were analyzed on an LTQ mass spectrometer following enrichment for phosphopeptides using titanium dioxide beads. In this manner, the authors detected a total of 506 phosphosites on 301 proteins and identified a dominant motif for M. tuberculosis STPKs, which was validated using synthetic peptides. This initial investigation reported 40% Ser: 60% Thr phosphorylation, and no Tyr phospho-sites—at the time of publication there was no conclusive molecular evidence for Tyr phosphorylation in M. tuberculosis, although there was a long-established association between Tyr phosphorylation and pathogenicity in other bacteria. (Ilan et al., 1999). Kusebauch et al. (2014) reported Tyr phosphorylation in M. tuberculosis for the first time, after establishing that the known M. tuberculosis STPKs have the capacity to phosphorylate Tyr, and then by carrying out LC MS/MS analysis on M. tuberculosis culture lysate enriched for phosphopeptides. In this manner, they detected 30 high-confidence Tyr phospho-sites on 17 M. tuberculosis proteins, contributing to a Ser: Thr: Tyr ratio of 34:62:4%. Intriguingly, these authors also found an additional 35 Tyr phosphorylation sites in publically accessible MS data from previously published proteomic studies of M. tuberculosis, where the assumption that there was no Tyr phosphorylation in M. tuberculosis had led the authors to overlook them. Subsequent MS based descriptions of the M. tuberculosis phosphoproteome have identified similar proportions of Tyr phosphorylation sites, some of which may be of particular importance in establishing virulence.

Recently, Nakedi et al. (2015) investigated the impact of protein phosphorylation in growth-related functions by measuring differential phosphorylation between two mycobacterial species during exponential growth phase—the fast growing, non-pathogenic, soil dwelling Mycobacterium smegmatis and the slow growing, attenuated strain of Mycobacterium bovis (BCG). BCG had consistently higher phosphorylation levels, with 289 phosphosites on 203 proteins, compared to M. smegmatis with 106 phosphosites found on 76 proteins. The phosphoproteins which were uniquely found in BCG were generally involved in cell growth and stress response. Even under optimal growth conditions, BCG appears to have a high level of phosphorylated stress response proteins which suggests the capability for quick on/off responses to stressors within the host, which ultimately allows the bacteria to respond rapidly and survive more effectively. The potential adaptive advantage for the pathogen may result in a fitness cost of slower growth. In a follow-up phosphoproteomic study, Zheng et al. (2015) found 659 phosphosites on 398 proteins in BCG harvested during stationary phase. The majority (40.1%) of identified phosphoproteins in this case were involved in regulation of metabolism. Again, these findings indicate that phosphorylation plays an important role in the slower metabolism of BCG, which may ultimately increase the capability for persistence within the host, and may be beneficial to the bacteria when faced with drug treatment (Evangelopoulos and McHugh, 2015).

A phosphoproteomic investigation of a hyper-virulent Beijing strain of M. tuberculosis by Fortuin et al. (2015) reported the identification of 414 phosphosites on 214 proteins. Of these, 252 were novel phosphosites which had not been identified in previous phosphoproteome research on the H37Rv strain. Since the capability for complex signaling is directly related to the number of phosphorylation events, it could be inferred that an increasing number of phosphorylation events may play a role in differentiating virulence in different M. tuberculosis strains. This is supported by findings that a highly virulent, drug resistant strain of Acinetobacter baumannii has almost double the number of phosphosites in comparison to the reference strain (Soares et al., 2014). It is also interesting to note that phosphorylation may be linked to drug resistance, which is of concern given the emergence of drug resistant strains of TB (Evangelopoulos and McHugh, 2015). Although the mechanism by which a bacterium might accumulate additional phosphosites is not fully understood, it is of interest that Fortuin et al. (2015) identified phosphorylated forms of 9 out of the 11 STPKs encoded by the M. tuberculosis genome in this hypervirulent Beijing strain (Prisic and Husson, 2014), while Prisic et al. (2010) only identified four in H37Rv.

Although our understanding of the specific activity of Mycobacterial STPKs is largely incomplete, some substrates and their downstream functions have been associated with specific kinases (Supplementary Table 1). While mass spectrometry is capable of identifying hundreds of phospho-substrates, more laborious methods are necessary to associate these substrates with their corresponding kinases. The challenges inherent in mass-spectrometry-based kinase substrate identification are discussed in more detail by Sherman and Grundner (2014). Parandhaman et al. (2014b) made use of a ΔPknE deletion mutant of M. tuberculosis to identify PknE substrates during NO stress in M. tuberculosis, and identified 68 phosphoproteins by combining 2D PAGE MS with phospho-serine and phospho-threonine specific antibodies. The candidate PknE substrates identified in this manner may play a role in dormancy within the macrophage, which may have implications for virulence, once again highlighting the importance of phosphorylation in allowing the bacterium to respond effectively to the host environment. Given this information, and somewhat surprisingly, there is evidence that the PknE gene is non-essential for growth of M. tuberculosis in culture (Sassetti et al., 2003). Indeed, in culture-based models it seems that only three of the STPKs available to M. tuberculosis are individually essential for growth: PknA and PknB (Wehenkel et al., 2008); and PknG, which is essential for survival of M. tuberculosis within the macrophage. Walburger et al. (2004) demonstrated that a strain of M. bovis BCG carrying an inactivated PknG gene showed no differences in growth or cell morphology in liquid medium to the wild type, whereas the mutant was unable to survive when inside a macrophage because the bacteria were no longer able to prevent lysosomal fusion. In many pathogenic bacteria, but particularly in M. tuberculosis, we are increasingly aware of the complexity of the host/pathogen interaction during disease progression, while being limited to culture or animal based models in our attempts to understand it1. The fact that M. tuberculosis has evolved to exist in the intracellular space is highlighted by the metabolic changes which are observed in intracellular M. tuberculosis (Lee et al., 2013), but we have yet to explore the consequences of phosphorylation for M. tuberculosis in vivo. It is conceivable that intracellular STPKs have different activity compared to culture-based systems, and high-throughput phosphoproteomic analysis of intracellular M. tuberculosis would allow us to better understand the role of phosphorylation in the host pathogen interaction.

Identifying functional phosphosites for further characterization

The aim of discovery-based proteomics has been to catalog as many proteins as possible in a sample, with the intent being to better understand a biological condition or response. However, the volumes of data generated in this manner have not necessarily achieved a deeper understanding of the biological systems in question. This problem is equally as confounding, if not more so, in phosphoproteomic investigations, since it is difficult to attribute biological significance to a discreet phosphorylation event. Many of the detected phosphorylation events reported by these large-scale studies require validation before we can begin to determine their function. To this end, meta-analysis of the available data may provide some insight for future investigations. Although the above-mentioned mycobacterial phosphoproteomic studies were conducted using different MS-based methodologies, and in different strains of mycobacteria, there are discreet phosphorylation events that were commonly observed in several datasets, and are therefore unlikely to be random. A phosphopeptide which is observed in more than one study, or across several mycobacterial strains, may therefore be the best starting point for further investigation in M. tuberculosis. To this end, here we present a compilation of commonly detected phosphopeptides/sites which may thus be of use for future functional phosphoproteomic investigations in the mycobacteria (Supplementary Table 2).

A total of 194 phosphopeptides representing 148 proteins were found to be represented by two or more sets of data according to the available published supplementary information. To facilitate comparison at the protein level, the peptide sequences were matched to H37Rv protein identifiers using the Protein Information Resource (PIR) batch peptide match tool against the Uniprot H37Rv proteome (Chen et al., 2013). GO analysis of the proteins corresponding to these shared phosphopeptides using STRAP 1.5 (Bhatia et al., 2009) revealed that the associated GO terms relate to broad regulatory functions, such as the regulation of cell metabolism, cellular processes, and growth (Figures 1A,B). While this is expected given the established role of phosphorylation in metabolic regulation in bacteria (Kochanowski et al., 2015), this is also potentially noteworthy as we are only beginning to unravel the importance of metabolic regulation for intracellular M. tuberculosis and how this relates to virulence (Eisenreich et al., 2010). Of particular interest are incidences where the more virulent clinical strain is phosphorylated on a different residue compared to the other strains, as in the example of the AEASIETPTPVQSQR peptide of TatA, a Sec-independent protein translocase protein, which was phosphorylated on T7 and/or T9 in M. bovis BCG and M. tuberculosis H37Rv but on S4 in the clinical strain. The functional significance of this difference remains unknown and should be validated and investigated, particularly in light of the contribution of the Tat pathway to virulence in M. tuberculosis (Feltcher et al., 2010). It should be noted that the utility of GO analysis in mycobacteria is limited by the availability of GO annotations and other resources such as KEGG pathway representation, for which coverage is generally poor.

Figure 1.

Figure 1

Summary of GO terms associated with proteins that were detected in more than one phosphoproteomic dataset, shown by (A) biological process (B) molecular function. GO analysis performed using STRAP 1.5.

Differential phosphorylation of the STPKs themselves can alter their enzymatic activity, and is another possible mechanism for altered pathogenicity in M. tuberculosis (Chopra et al., 2003; Durán et al., 2005). Supplementary Table 2 highlights that phosphorylation is commonly detected in PknA, B, D, E, G, and H in these mycobacteria; however the differences in localized phosphosites between the virulent and less virulent strains are more pronounced in peptides corresponding to PknA, D, and G. Having already established the importance of PknA (Singh et al., 2006) and G (Walburger et al., 2004) for survival within the macrophage, the biological significance of these differences in phosphorylation and how they contribute virulence should now be ascertained. Forrellad et al. (2013) published a summary of the known virulence factors in the M. tuberculosis complex and their putative contribution to virulence. Cross referencing their table of results to ours identified proteins which are known virulence factors which are also commonly detected in these phosphoproteomic datasets. These proteins and their putative role in virulence in the M. tuberculosis complex are presented in Table 2. Included in these are some previously mentioned STPKs, as well as the proteins KatG, EspR, and IdeR.

Table 2.

Previously reported virulence factors in the M. tuberculosis complex which have been identified in more than one phosphoproteomic dataset, and their putative role in virulence.

Accession Protein names Phosphopeptides/sites Putative role in virulence References
P9WI73 Serine/threonine-protein kinase PknG SGPGTQPADAQTATSATVR Unclear, possibly growth and metabolism Nguyen et al., 2005
P9WI77 Serine/threonine-protein kinase PknE LPVPSTHPVSPGTR MAPK signaling, survival Parandhaman et al., 2014a
P9WI79 Serine/threonine-protein kinase PknD WSPGDSATVAGPLAADSR Unclear, plays a role in TB infection of the CNS Be et al., 2012
P9WIE5 Catalase-peroxidase (CP) (Peroxidase/catalase) KatG DAITSGIEVVWTNTPTK Antioxidant Ng et al., 2004
P9WJB7 Nucleoid-associated protein EspR AHGLPSAAQQK Transcriptional regulation Blasco et al., 2012
P9WMH1 Iron-dependent repressor IdeR MNELVDTTEMYLR Iron dependent regulation Banerjee et al., 2011
I6Y748 Membrane protein DPPTDPNLR Unknown n/a

The commonly detected phosphopeptide is indicated in bold, along with phosphosites that have been confirmed in more than one study.

Current state of phosphoproteomics

Currently, the mycobacterial phosphoproteome has been qualitatively described, which has identified many high confidence phosphosites. However, a complete description of the phosphoproteome should include quantitative information for the specific phosphosite in question as well as for the phosphorylated protein. In addition, most of the available phosphoproteomic data is for bacterial culture under a single condition, and yet we recognize that phosphorylation is dynamic and can change rapidly (Macek et al., 2009). In order to address this, it is important to incorporate multiple time points and experimental conditions in future phosphoproteomic investigations. These objectives are specifically challenging for mass spectrometry-based proteomics, and despite promising technological advances the mycobacterial phosphoproteome has not yet been quantitatively assessed (de la Fuente van Bentem et al., 2008). There are many available quantitative proteomic tools which are applicable in bacterial phosphoproteomics, which have been discussed in detail elsewhere (Jers et al., 2008; Macek et al., 2009), however, not all of these are suitable for the mycobacteria. SILAC, for example, has been used successfully to quantify proteins in the bacterium Bacillus subtilis (Ravikumar et al., 2014), but is not currently possible in M. tuberculosis because the available lysine deficient mutants are not viable for SILAC. Alternative quantitative methods include label-free quantitation, which has the benefit of cost effectiveness allowing for multiple time points/conditions to be explored, or dimethyl labeling, which is a promising alternative to iTRAQ and other label-based techniques (Lau et al., 2014). iTRAQ has been successfully used to quantify the phosphorylation of arginine in B. subtilis (Schmidt et al., 2014), and therefore is suitable for measuring S/T/Y phosphorylation in bacterial systems, but is limited by the number of samples that can be analyzed concurrently and the high cost of the iTRAQ reagents. Validation of phosphoproteomic data using targeted proteomics along with specialized analysis software such as Skyline is an exciting prospect, as these powerful tools have the capability to validate specific phosphosites as well as providing quantitative information. The absolute quantitation of modified peptides is possible through a combination of heavy-labeled AQUA peptides and selected reaction monitoring (SRM) MS, although the successful use of this strategy has not yet been reported in bacteria (Kirkpatrick et al., 2005).

Recommendations for future research

The field of phosphoproteomics would benefit greatly from an integrated, easily accessible database containing all available information, which would facilitate meta-analysis of PTMs between multiple datasets. Furthermore, such a database for all known PTMs would allow for more in-depth analysis of the cross-talk between bacterial PTMs and how this may relate to pathogenicity, which has been discussed in a review by Soufi et al. (2012). Such a resource could provide a standardized format for reporting PTMs, as well as the opportunity to automatically update database accession numbers for modified proteins—which would in turn facilitate more meaningful comparison between different species or strains. Significant challenges exist prior to the development of such a database, including the lack of standardized reporting in currently published studies. However, the capacity to detect PTMs using MS will only increase with improving technology and the interpretation and management of the data thus generated is therefore crucial if we are to translate this into meaningful clinical applications. Through better understanding of the function of regulatory PTMs in M. tuberculosis, we may reveal the means to control or cure it.

Author contributions

CA Wrote the original draft of this paper, read, and edited final draft. BC Edited draft submitted by CA, compiled data from phosphoproteomic reviews and performed meta-data analysis, put together final draft of paper. NS Supervised revisions on paper, provided editing support, and directed the topic to be covered by the review. JB Provided supervision and guidance throughout and offered editing support.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

BC and NS thank the South African Medical Research Council for Fellowships. JB acknowledges the South African National Research Foundation for the Research Chair grant. NS acknowledges support in part by the National Research Foundation of South Africa (Grant Numbers 98963 and 95984).

Footnotes

1MISSING:pmid:22320122. MISSING:pmid:22320122. (2016).

Supplementary material

The Supplementary Material for this article can be found online at: http://journal.frontiersin.org/article/10.3389/fmicb.2016.00141

References

  1. Bakal C. J., Davies J. E. (2000). No longer an exclusive club: eukaryotic signalling domains in bacteria. Trends Cell Biol. 10, 32–38. 10.1016/S0962-8924(99)01681-5 [DOI] [PubMed] [Google Scholar]
  2. Banerjee S., Farhana A., Ehtesham N. Z., Hasnain S. E. (2011). Iron acquisition, assimilation and regulation in mycobacteria. Infect Genet. Evol. 11, 825–838. 10.1016/j.meegid.2011.02.016 [DOI] [PubMed] [Google Scholar]
  3. Be N. A., Bishai W. R., Jain S. K. (2012). Role of Mycobacterium tuberculosis pknD in the pathogenesis of central nervous system tuberculosis. BMC Microbiol. 12:7. 10.1186/1471-2180-12-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bhatia V. N., Perlman D. H., Costello C. E., McComb M. E. (2009). Software tool for researching annotations of proteins: open-source protein annotation software with data visualization. Anal. Chem. 81, 9819–9823. 10.1021/ac901335x [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Blasco B., Chen J. M., Hartkoorn R., Sala C., Uplekar S., Rougemont J., et al. (2012). Virulence regulator EspR of Mycobacterium tuberculosis is a nucleoid-associated protein. PLoS Pathog. 8:e1002621. 10.1371/journal.ppat.1002621 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cain J. A., Solis N., Cordwell S. J. (2014). Beyond gene expression: the impact of protein post-translational modifications in bacteria. J. Proteomics 97, 265–286. 10.1016/j.jprot.2013.08.012 [DOI] [PubMed] [Google Scholar]
  7. Chen C., Li Z., Huang H., Suzek B. E., Wu C. H., UniProt Consortium (2013). A fast peptide match service for uniprot knowledgebase. Bioinformatics 29, 2808–2809. 10.1093/bioinformatics/btt484 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chopra P., Singh B., Singh R., Vohra R., Koul A., Meena L. S., et al. (2003). Phosphoprotein phosphatase of Mycobacterium tuberculosis dephosphorylates serine-threonine kinases PknA and PknB. Biochem. Biophys. Res. Commun. 311, 112–120. 10.1016/j.bbrc.2003.09.173 [DOI] [PubMed] [Google Scholar]
  9. de la Fuente van Bentem S., Mentzen W. I., de la Fuente A., Hirt H. (2008). Towards functional phosphoproteomics by mapping differential phosphorylation events in signaling networks. Proteomics 8, 4453–4465. 10.1002/pmic.200800175 [DOI] [PubMed] [Google Scholar]
  10. Durán R., Villarino A., Bellinzoni M., Wehenkel A., Fernandez P., Boitel B., et al. (2005). Conserved autophosphorylation pattern in activation loops and juxtamembrane regions of Mycobacterium tuberculosis Ser/Thr protein kinases. Biochem. Biophys. Res. Commun. 333, 858–867. 10.1016/j.bbrc.2005.05.173 [DOI] [PubMed] [Google Scholar]
  11. Eisenreich W., Dandekar T., Heesemann J., Goebel W. (2010). Carbon metabolism of intracellular bacterial pathogens and possible links to virulence. Nat. Rev. Microbiol. 8, 401–412. 10.1038/nrmicro2351 [DOI] [PubMed] [Google Scholar]
  12. Evangelopoulos D., McHugh T. D. (2015). Improving the tuberculosis drug development pipeline. Chem. Biol. Drug Des. 86, 951–960. 10.1111/cbdd.12549 [DOI] [PubMed] [Google Scholar]
  13. Feltcher M. E., Sullivan J. T., Braunstein M. (2010). Protein export systems of Mycobacterium tuberculosis: novel targets for drug development? Future Microbiol. 5, 1581–1597. 10.2217/fmb.10.112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Forrellad M. A., Klepp L. I., Gioffré A., Sabio y Garcia J., Morbidoni H. R., de la Paz Santangelo M., et al. (2013). Virulence factors of the Mycobacterium tuberculosis complex. Virulence 4, 3–66. 10.4161/viru.22329 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fortuin S., Tomazella G. G., Nagaraj N., Sampson S. L., van Pittius N. C. G., Soares N. C., et al. (2015). Phosphoproteomics analysis of a clinical Mycobacterium tuberculosis Beijing isolate: expanding the mycobacterial phosphoproteome catalog. Front. Microbiol. 6:6. 10.3389/fmicb.2015.00006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ge R., Shan W. (2011). Bacterial phosphoproteomic analysis reveals the correlation between protein phosphorylation and bacterial pathogenicity. Genomics. Proteomics Bioinformatics 9, 119–127. 10.1016/S1672-0229(11)60015-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gengenbacher M., Kaufmann S. H. (2012). Mycobacterium tuberculosis: success through dormancy. FEMS Microbiol. Rev. 36, 514–532. 10.1111/j.1574-6976.2012.00331.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ilan O., Bloch Y., Frankel G., Ullrich H., Geider K., Rosenshine I. (1999). Protein tyrosine kinases in bacterial pathogens are associated with virulence and production of exopolysaccharide. EMBO J. 18, 3241–3248. 10.1093/emboj/18.12.3241 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jers C., Soufi B., Grangeasse C., Deutscher J., Mijakovic I. (2008). Phosphoproteomics in bacteria: towards a systemic understanding of bacterial phosphorylation networks. Expert Rev. Proteomics 5, 619–627. 10.1586/14789450.5.4.619 [DOI] [PubMed] [Google Scholar]
  20. Kirkpatrick D. S., Gerber S. A., Gygi S. P. (2005). The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications. Methods 35, 265–273. 10.1016/j.ymeth.2004.08.018 [DOI] [PubMed] [Google Scholar]
  21. Kochanowski K., Sauer U., Noor E. (2015). Posttranslational regulation of microbial metabolism. Curr. Opin. Microbiol. 27, 10–17. 10.1016/j.mib.2015.05.007 [DOI] [PubMed] [Google Scholar]
  22. Kusebauch U., Ortega C., Ollodart A., Rogers R. S., Sherman D. R., Moritz R. L., et al. (2014). Mycobacterium tuberculosis supports protein tyrosine phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 111, 9265–9270. 10.1073/pnas.1323894111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lau H.-T., Suh H. W., Golkowski M. G., Ong S.-E. (2014). Comparing SILAC- and stable isotope dimethyl-labeling approaches for quantitative proteomics. J. Proteome Res. 13, 4164–4174. 10.1021/pr500630a [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lee W., VanderVen B. C., Fahey R. J., Russell D. G. (2013). Intracellular Mycobacterium tuberculosis exploits host-derived fatty acids to limit metabolic stress. J. Biol. Chem. 288, 6788–6800. 10.1074/jbc.M112.445056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Macek B., Gnad F., Soufi B., Kumar C., Olsen J. V., Mijakovic I., et al. (2008). Phosphoproteome analysis of E. coli reveals evolutionary conservation of bacterial Ser/Thr/Tyr phosphorylation. Mol. Cell. Proteomics 7, 299–307. 10.1074/mcp.M700311-MCP200 [DOI] [PubMed] [Google Scholar]
  26. Macek B., Mann M., Olsen J. V. (2009). Global and site-specific quantitative phosphoproteomics: principles and applications. Annu. Rev. Pharmacol. Toxicol. 49, 199–221. 10.1146/annurev.pharmtox.011008.145606 [DOI] [PubMed] [Google Scholar]
  27. Macek B., Mijakovic I., Olsen J. V., Gnad F., Kumar C., Jensen P. R., et al. (2007). The serine/threonine/tyrosine phosphoproteome of the model bacterium Bacillus subtilis. Mol. Cell. Proteomics 6, 697–707. 10.1074/mcp.M600464-MCP200 [DOI] [PubMed] [Google Scholar]
  28. Mann M., Jensen O. N. (2003). Proteomic analysis of post-translational modifications. Nat. Biotechnol. 21, 255–261. 10.1038/nbt0303-255 [DOI] [PubMed] [Google Scholar]
  29. Mijakovic I. (2010). Protein phosphorylation in bacteria. Issues 5, 21–25. [Google Scholar]
  30. Misra S. K., Milohanic E., Aké F., Mijakovic I., Deutscher J., Monnet V., et al. (2011). Analysis of the serine/threonine/tyrosine phosphoproteome of the pathogenic bacterium Listeria monocytogenes reveals phosphorylated proteins related to virulence. Proteomics 11, 4155–4165. 10.1002/pmic.201100259 [DOI] [PubMed] [Google Scholar]
  31. Nakedi K. C., Nel A. J., Garnett S., Blackburn J. M., Soares N. C. (2015). Comparative Ser/Thr/Tyr phosphoproteomics between two mycobacterial species: the fast growing Mycobacterium smegmatis and the slow growing Mycobacterium bovis BCG. Front. Microbiol. 6:237. 10.3389/fmicb.2015.00237 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Ng V. H., Cox J. S., Sousa A. O., MacMicking J. D., McKinney J. D. (2004). Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol. Microbiol. 52, 1291–1302. 10.1111/j.1365-2958.2004.04078.x [DOI] [PubMed] [Google Scholar]
  33. Nguyen L., Walburger A., Houben E., Koul A., Muller S., Morbitzer M., et al. (2005). Role of protein kinase G in growth and glutamine metabolism of Mycobacterium bovis BCG. J. Bacteriol. 187, 5852–5856. 10.1128/JB.187.16.5852-5856.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Nørregaard Jensen O. (2004). Modification-specific proteomics: characterization of post-translational modifications by mass spectrometry. Curr. Opin. Chem. Biol. 8, 33–41. 10.1016/j.cbpa.2003.12.009 [DOI] [PubMed] [Google Scholar]
  35. Parandhaman D. K., Hanna L. E., Narayanan S. (2014a). PknE, a serine/threonine protein kinase of Mycobacterium tuberculosis initiates survival crosstalk that also impacts HIV coinfection. PLoS ONE 9:e83541. 10.1371/journal.pone.0083541 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  36. Parandhaman D. K., Sharma P., Bisht D., Narayanan S. (2014b). Proteome and phosphoproteome analysis of the serine/threonine protein kinase E mutant of Mycobacterium tuberculosis. Life Sci. 109, 116–126. 10.1016/j.lfs.2014.06.013 [DOI] [PubMed] [Google Scholar]
  37. Prisic S., Dankwa S., Schwartz D., Chou M. F., Locasale J. W., Kang C.-M., et al. (2010). Extensive phosphorylation with overlapping specificity by Mycobacterium tuberculosis serine/threonine protein kinases. Proc. Natl. Acad. Sci. U.S.A. 107, 7521–7526. 10.1073/pnas.0913482107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Prisic S., Husson R. N. (2014). Mycobacterium tuberculosis serine/threonine protein kinases. Microbiol. Spectr. 2. 10.1128/microbiolspec.MGM2-0006-2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Ravikumar V., Shi L., Krug K., Derouiche A., Jers C., Cousin C., et al. (2014). Quantitative phosphoproteome analysis of Bacillus subtilis reveals novel substrates of the kinase PrkC and phosphatase PrpC. Mol. Cell. Proteomics 13, 1965–1978. 10.1074/mcp.M113.035949 [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sassetti C. M., Boyd D. H., Rubin E. J. (2003). Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol. 48, 77–84. 10.1046/j.1365-2958.2003.03425.x [DOI] [PubMed] [Google Scholar]
  41. Schmidt A., Trentini D. B., Spiess S., Fuhrmann J., Ammerer G., Mechtler K., et al. (2014). Quantitative phosphoproteomics reveals the role of protein arginine phosphorylation in the bacterial stress response. Mol. Cell. Proteomics 13, 537–550. 10.1074/mcp.M113.032292 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Schnappinger D., Ehrt S., Voskuil M. I., Liu Y., Mangan J. A., Monahan I. M., et al. (2003). Transcriptional adaptation of Mycobacterium tuberculosis within macrophages insights into the phagosomal environment. J. Exp. Med. 198, 693–704. 10.1084/jem.20030846 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Semanjski M., Macek B. (2016). Shotgun proteomics of bacterial pathogens: advances, challenges and clinical implications. Expert Rev. Proteomics 13, 139–156. 10.1586/14789450.2016.1132168 [DOI] [PubMed] [Google Scholar]
  44. Sherman D. R., Grundner C. (2014). Agents of change-concepts in Mycobacterium tuberculosis Ser/Thr/Tyr phosphosignalling. Mol. Microbiol. 94, 231–241. 10.1111/mmi.12747 [DOI] [PubMed] [Google Scholar]
  45. Singh A., Singh Y., Pine R., Shi L., Chandra R., Drlica K. (2006). Protein kinase I of Mycobacterium tuberculosis: cellular localization and expression during infection of macrophage-like cells. Tuberculosis (Edinb) 86, 28–33. 10.1016/j.tube.2005.04.002 [DOI] [PubMed] [Google Scholar]
  46. Soares N. C., Spät P., Krug K., and Macek, B. (2013). Global dynamics of the Escherichia coli proteome and phosphoproteome during growth in minimal medium. J. Proteome Res. 12, 2611–2621. 10.1021/pr3011843 [DOI] [PubMed] [Google Scholar]
  47. Soares N. C., Spät P., Méndez J. A., Nakedi K., Aranda J., Bou G. (2014). Ser/Thr/Tyr phosphoproteome characterization of Acinetobacter baumannii: comparison between a reference strain and a highly invasive multidrug-resistant clinical isolate. J. Proteomics 102, 113–124. 10.1016/j.jprot.2014.03.009 [DOI] [PubMed] [Google Scholar]
  48. Soufi B., Soares N. C., Ravikumar V., Macek B. (2012). Proteomics reveals evidence of cross-talk between protein modifications in bacteria: focus on acetylation and phosphorylation. Curr. Opin. Microbiol. 15, 357–363. 10.1016/j.mib.2012.05.003 [DOI] [PubMed] [Google Scholar]
  49. Stülke J. (2010). More than just activity control: phosphorylation may control all aspects of a protein's properties. Mol. Microbiol. 77, 273–275. 10.1111/j.1365-2958.2010.07228.x [DOI] [PubMed] [Google Scholar]
  50. Sun X., Ge F., Xiao C.-L., Yin X.-F., Ge R., Zhang L.-H., et al. (2009). Phosphoproteomic analysis reveals the multiple roles of phosphorylation in pathogenic bacterium Streptococcus pneumoniae. J. Proteome Res. 9, 275–282. 10.1021/pr900612v [DOI] [PubMed] [Google Scholar]
  51. Van Els C. A. C. M., Corbière V., Smits K., van Gaans-van den Brink J. A. M., Poelen M. C. M., Mascart F., et al. (2014). Toward Understanding the Essence of Post-Translational Modifications for the Mycobacterium tuberculosis Immunoproteome. Front. Immunol. 5:361. 10.3389/fimmu.2014.00361 [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Walburger A., Koul A., Ferrari G., Nguyen L., Prescianotto-Baschong C., Huygen K., et al. (2004). Protein kinase G from pathogenic mycobacteria promotes survival within macrophages. Science 304, 1800–1804. 10.1126/science.1099384 [DOI] [PubMed] [Google Scholar]
  53. Wehenkel A., Bellinzoni M., Graña M., Duran R., Villarino A., Fernandez P., et al. (2008). Mycobacterial Ser/Thr protein kinases and phosphatases: physiological roles and therapeutic potential. Biochim. Biophys. Acta 1784, 193–202. 10.1016/j.bbapap.2007.08.006 [DOI] [PubMed] [Google Scholar]
  54. Zheng J., Liu L., Liu B., Jin Q. (2015). Phosphoproteomic analysis of bacillus Calmette-Guérin using gel-based and gel-free approaches. J. Proteomics 126, 189–199. 10.1016/j.jprot.2015.06.003 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Frontiers in Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES